NCT03733496View on ClinicalTrials.gov

Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies

CompletedOBSERVATIONAL
Enrollment

14

Participants

Timeline

Start Date

August 24, 2018

Primary Completion Date

July 18, 2023

Study Completion Date

July 18, 2023

Conditions
Parkinson's Disease
Trial Locations (3)

30322

Emory University, Atlanta

43210

Ohio State University, Columbus

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

Voyager Therapeutics
All Listed Sponsors
collaborator

Voyager Therapeutics

INDUSTRY

lead

Neurocrine Biosciences

INDUSTRY